Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
29,149,043
-
Total 13F shares
-
14,527,277
-
Share change
-
+1,233,283
-
Total reported value
-
$525,046,889
-
Put/Call ratio
-
112%
-
Price per share
-
$36.14
-
Number of holders
-
136
-
Value change
-
+$40,323,740
-
Number of buys
-
89
-
Number of sells
-
49
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q3 2015
As of 30 Sep 2015,
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,527,277 shares.
The largest 10 holders included
Apex Capital Management, BlackRock Fund Advisors, EAGLE ASSET MANAGEMENT INC, FMR LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, Krensavage Asset Management, LLC, Invesco Ltd., VANGUARD GROUP INC, and Consonance Capital Management LP.
This page lists
136
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.